Bharat Biotech

Scientists strike note of caution as 'Made in India' vaccine programme gains momentum

Phase 1 trials are small-scale, usually involving few participants, to assess whether the vaccine is safe for humans.

published on : 4th July 2020

India's first COVID-19 vaccine candidate 'COVAXIN' gets DCGI approval for human clinical trials

The permission for human clinical trials was granted by DCGI after the company submitted results generated from preclinical studies, demonstrating safety and immune response.

published on : 29th June 2020

$16 million grant for Bharat Biotech, IVI

The CEPI will provide funds upto $14.1 million to the consortium, for the manufacturing of vaccine and clinical development of a two-dose live-inactivated vaccine against Chikungunya.

published on : 4th June 2020

Coming soon! Bharat Biotech's CoroFlu vaccine to beat coronavirus pandemic

Bharat Biotech on Friday announced that a unique intranasal vaccine, CoroFlu, is under development for Covid-19 and human clinical trials could begin by the fall of 2020.

published on : 4th April 2020